The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD
1 other identifier
observational
122
0 countries
N/A
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the airways and lungs that develops against harmful particles or gases with exacerbations. Coexistence of bronchiectasis with COPD may lead to worsening of the functional parameters as well as alteration of the microbiological pattern in exacerbations and may negatively affect the exacerbation result parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2017
CompletedFirst Submitted
Initial submission to the registry
May 13, 2019
CompletedFirst Posted
Study publicly available on registry
May 15, 2019
CompletedMay 17, 2019
May 1, 2019
4.9 years
May 13, 2019
May 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Charlson Comorbidity Index
Comorbidity scores
1 hour
Secondary Outcomes (1)
Spirometry
1 hour
Study Arms (2)
COPD exacerbation without Bronchiectasis
COPD patients who have been in exacerbation period and have no bronchiectasis
COPD exacerbation with Bronchiectasis
COPD patients who have been in exacerbation period and have bronchiectasis
Interventions
Eligibility Criteria
Patient with COPD exacerbation
You may qualify if:
- Patients who underwent thoracic tomography in the last year according to index exacerbation date were included in the study
You may not qualify if:
- Cases that mimic COPD exacerbation (pneumonia, pulmonary thromboembolism, pulmonary congestion, pneumothorax, pleural effusion, lung malignancy, asthma, asthma-COPD overlap syndrome) and patients admitted to the intensive care unit were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nurdan Kokturk, Professor
Gazi University Faculty of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
May 13, 2019
First Posted
May 15, 2019
Study Start
January 25, 2010
Primary Completion
December 25, 2014
Study Completion
January 25, 2017
Last Updated
May 17, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share